Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1997 Feb;65(2):798–800. doi: 10.1128/iai.65.2.798-800.1997

Protection against infection in mice vaccinated with a Brucella abortus mutant.

M L Boschiroli 1, S L Cravero 1, A I Arese 1, E Campos 1, O L Rossetti 1
PMCID: PMC176128  PMID: 9009345

Abstract

This study determines whether a genetically engineered mutant of Brucella abortus, strain M-1, possesses differences in protective properties compared to the parental strain, vaccine S19. M-1 is a mutant unable to express BP26, a periplasmic protein with potential use in diagnosis. Mice vaccinated with S19 developed antibodies against BP26, while those vaccinated with M-1 did not. However, mice vaccinated with S19 or M-1 were similarly protected against challenge with pathogenic strain 2308, suggesting that the lack of BP26 does not affect the induction of the protective immune response exerted by S19. These and previous results showing that bacterial invasion and growth or replication in mouse spleens were indistinguishable between strains M-1 and S19 could indicate that the mutant is an attenuated strain which maintains the same protective properties as S19.

Full Text

The Full Text of this article is available as a PDF (187.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Araya L. N., Elzer P. H., Rowe G. E., Enright F. M., Winter A. J. Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus. J Immunol. 1989 Nov 15;143(10):3330–3337. [PubMed] [Google Scholar]
  2. Bosseray N., Plommet M. Brucella suis S2, brucella melitensis Rev. 1 and Brucella abortus S19 living vaccines: residual virulence and immunity induced against three Brucella species challenge strains in mice. Vaccine. 1990 Oct;8(5):462–468. doi: 10.1016/0264-410x(90)90247-j. [DOI] [PubMed] [Google Scholar]
  3. Brooks-Worrell B. M., Splitter G. A. Antigens of Brucella abortus S19 immunodominant for bovine lymphocytes as identified by one- and two-dimensional cellular immunoblotting. Infect Immun. 1992 Jun;60(6):2459–2464. doi: 10.1128/iai.60.6.2459-2464.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cheville N. F., Olsen S. C., Jensen A. E., Stevens M. G., Florance A. M., Houng H. S., Drazek E. S., Warren R. L., Hadfield T. L., Hoover D. L. Bacterial persistence and immunity in goats vaccinated with a purE deletion mutant or the parental 16M strain of Brucella melitensis. Infect Immun. 1996 Jul;64(7):2431–2439. doi: 10.1128/iai.64.7.2431-2439.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cheville N. F., Stevens M. G., Jensen A. E., Tatum F. M., Halling S. M. Immune responses and protection against infection and abortion in cattle experimentally vaccinated with mutant strains of Brucella abortus. Am J Vet Res. 1993 Oct;54(10):1591–1597. [PubMed] [Google Scholar]
  6. Crawford R. M., Van De Verg L., Yuan L., Hadfield T. L., Warren R. L., Drazek E. S., Houng H. H., Hammack C., Sasala K., Polsinelli T. Deletion of purE attenuates Brucella melitensis infection in mice. Infect Immun. 1996 Jun;64(6):2188–2192. doi: 10.1128/iai.64.6.2188-2192.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Drazek E. S., Houng H. S., Crawford R. M., Hadfield T. L., Hoover D. L., Warren R. L. Deletion of purE attenuates Brucella melitensis 16M for growth in human monocyte-derived macrophages. Infect Immun. 1995 Sep;63(9):3297–3301. doi: 10.1128/iai.63.9.3297-3301.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Halling S. M., Detilleux P. G., Tatum F. M., Judge B. A., Mayfield J. E. Deletion of the BCSP31 gene of Brucella abortus by replacement. Infect Immun. 1991 Nov;59(11):3863–3868. doi: 10.1128/iai.59.11.3863-3868.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jiménez de Bagüs M. P., Elzer P. H., Jones S. M., Blasco J. M., Enright F. M., Schurig G. G., Winter A. J. Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis. Infect Immun. 1994 Nov;62(11):4990–4996. doi: 10.1128/iai.62.11.4990-4996.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Latimer E., Simmers J., Sriranganathan N., Roop R. M., 2nd, Schurig G. G., Boyle S. M. Brucella abortus deficient in copper/zinc superoxide dismutase is virulent in BALB/c mice. Microb Pathog. 1992 Feb;12(2):105–113. doi: 10.1016/0882-4010(92)90113-3. [DOI] [PubMed] [Google Scholar]
  11. Lin J., Adams L. G., Ficht T. A. Immunological response to the Brucella abortus GroEL homolog. Infect Immun. 1996 Oct;64(10):4396–4400. doi: 10.1128/iai.64.10.4396-4400.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Rossetti O. L., Arese A. I., Boschiroli M. L., Cravero S. L. Cloning of Brucella abortus gene and characterization of expressed 26-kilodalton periplasmic protein: potential use for diagnosis. J Clin Microbiol. 1996 Jan;34(1):165–169. doi: 10.1128/jcm.34.1.165-169.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Schurig G. G., Roop R. M., 2nd, Bagchi T., Boyle S., Buhrman D., Sriranganathan N. Biological properties of RB51; a stable rough strain of Brucella abortus. Vet Microbiol. 1991 Jul;28(2):171–188. doi: 10.1016/0378-1135(91)90091-s. [DOI] [PubMed] [Google Scholar]
  14. Stevens M. G., Olsen S. C., Pugh G. W., Jr, Brees D. Comparison of immune responses and resistance to brucellosis in mice vaccinated with Brucella abortus 19 or RB51. Infect Immun. 1995 Jan;63(1):264–270. doi: 10.1128/iai.63.1.264-270.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Stevens M. G., Olsen S. C., Pugh G. W., Jr, Palmer M. V. Immune and pathologic responses in mice infected with Brucella abortus 19, RB51, or 2308. Infect Immun. 1994 Aug;62(8):3206–3212. doi: 10.1128/iai.62.8.3206-3212.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES